Kinetic parameters of amikacin in cystic fibrosis children

Postantibiotic Suppression of Bacterial Growth

R. W. Bundtzen, Andreas Gerber, David L. Cohn et al. · Clinical Infectious Diseases · 1981 · 313 citations

Life Sciences, Microbiology, Pharmacology +15

Risk Factors for the Development of Auditory Toxicity in Patients Receiving Aminoglycosides

Regina Moore, C. R. Smith, P. S. Lietman · The Journal of Infectious Diseases · 1984 · 238 citations

Medicine, Audiology, Pharmacology +17

MICROBIOLOGY OF LUNG INFECTIONS IN CYSTIC FIBROSIS PATIENTS

Niels Høiby · Acta Paediatrica · 1982 · 228 citations

Life Sciences, Infectious Diseases, Microbiology +15

Disposition of tobramycin in patients with cystic fibrosis: A prospective controlled study

Jack Lévy, Arnold L. Smith, Jeffrey R. Koup et al. · The Journal of Pediatrics · 1984 · 126 citations

Medicine, Clinical Pharmacokinetics, Pharmacology +5

Dosing implications of altered gentamicin disposition in patients with cystic fibrosis

Gregory L. Kearns, D Pharm, Bettina C. Hilman et al. · The Journal of Pediatrics · 1982 · 108 citations

Pharmacy, Clinical Pharmacokinetics, Pharmacokinetics +13